Abstract
To this day, tuberculosis (TB) continues to pose a significant global health burden. The World Health Organization’s Expanded Programme on Immunization (EPI) recommends the bacille Calmette-Guérin (BCG) vaccine for infants to protect against the haematogenous spread of primary TB and other more severe types of TB infection. We report an eight-month-old boy who presented to the Armed Forces Hospital, Muscat, Oman, in 2015 with a one-month history of intermittent fever associated with a limited range of motion in the right hip area. He was up-to-date with his EPI vaccinations and had no history of exposure to individuals with TB infections. He was initially treated for bacterial septic arthritis; however, a GeneXpert TB assay revealed the presence of Mycobacterium tuberculosis, BCG strain. To the best of the authors’ knowledge, this is the first documented case from Oman of a child with TB hip osteomyelitis due to a BCG vaccination.
Publication Date
10-10-2017
First Page
358
Last Page
362
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Recommended Citation
Al-Azri, Mohammed S.; Manarang, Jazel; and Al-Mufargi, Yaqoub
(2017)
"Bacille Calmette-Guérin Vaccine-Induced Tuberculous Hip Osteomyelitis in an Infant : Case report,"
Sultan Qaboos University Medical Journal: Vol. 17: 358-362.
DOI: https://doi.org/10.18295/squmj.2017.17.03.019
